Tech Company Financing Transactions
NeoChord Funding Round
On 9/13/2017, NeoChord raised $4 million in funding from private investors.
Transaction Overview
Company Name
Announced On
9/13/2017
Transaction Type
Debt
Amount
$4,032,664
Round
Undisclosed
Investors
Proceeds Purpose
Proceeds purposes were not disclosed. 27 investors participated in the offering. The amount may include options, warrants or other securities. Contact technology company for investment details, if applicable. Not an offer or solicitation for the sale of securities or debt. SEC regulatory filing.
Company Information
Company Status
Private & Independent
Industry
Medical Devices & Instruments
Mailing Address
5402 Parkdale Dr. 160
St. Louis Park, MN 55416
USA
St. Louis Park, MN 55416
USA
Phone
Website
Email Address
Overview
NeoChord is a venture backed medical device company, is investigating minimally invasive technology intended to transform the treatment of degenerative mitral regurgitation.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
David Chung
Chief Financial Officer
Ronald Nelson
Chief Medical Officer
Ranny Chitwood
VP - Operations
Annette Doxon
VP - R & D
Daryl Edmiston
VP - Sales
Alex Jonkers
Browse more venture capital transactions:
Prev: 9/13/2017: EEVO venture capital transaction
Next: 9/13/2017: Diagram venture capital transaction
Share this article
About Database of VC Transactions
We do our best to record every notable VC transaction. VC investment data records reported here are sourced from news reports and company announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs